FDA panel recommends Novavax COVID-19 vaccine be the fourth allowed for use in US
A federal advisory committee recommended Tuesday that a fourth COVID-19 vaccine be authorized for use in the USA, this one from Novavax, a company based in Gaithersburg, Maryland.
Reply
You must be logged in to post a comment.